|CCL 06.03.09 Protein Folding Disorders, Baltimore, MD|
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Sat Oct 22 17:02:48 2005
Subject: 06.03.09 Protein Folding Disorders, Baltimore, MD
Protein Folding Disorders, Baltimore, MD March 9-10, 2006 http://www.healthtech.com/2006/pfd/index.asp Alzheimers, Parkinson's Disease, one of the inherited forms of emphysema, CJD, Cystic Fibrosis, Type 2 Diabetes, and even some cancers are all related to the abnormal folding of proteins within the body. These devastating diseases cause untold misery, extracting both monetary and human tolls. This highly focused conference will discuss strategies for elucidating protein misfolding mechanisms, methods for improved study of these events and applications to the development of effective drug discovery and development for the treatment of these disorders. Researchers doing work in any related research areas are encouraged to participate. Scientific Advisors Dr. Steve Abcouwer, Penn State University Hershey Medical Center Dr. Susan M. Catalano, Acumen Pharmaceuticals, Inc. Thursday March 9 Therapy Shared session with Transmissible Spongiform Encephalopathies SCIENCE AND POLICY: Joint FDA/USDA Panel on TSE-Safe Products: The Federal Role Shared session with Transmissible Spongiform Encephalopathies Friday March 10 Advances in the Science ls Cause Disease? Dr. Bruce Kagan, Professor, Psychiatry, UCLA Synthetic Mammalian Prions: Hierarchical Assembly and Substructure of Amyloid Fibrils VCP/p97 is Involved in Endoplasmic Reticulum Associated Degradation of CFTR: Implications in Cystic Fibrosis Dr. Neeraj Vij, Pediatric, Pulmonary, Johns Hopkins University Screening and Assays Molecular Chaperones are Required for the Mobility of Nuclear Receptors in Living Cells Dr. Gordon Hager, Lab Chief, Receptor Biology and Gene Expression, National Cancer Institute Development of a Screening Tool for Compounds that Inhibit the Formation of Beta Amyloid Oligomers RNAi Screening to Identify Genetic Factors Associated With Parkinson's Disease Dr. Guy Caldwell, Associate Professor, Biological Sciences, The University of Alabama Applications Understanding and Preventing the Initial Events in Amyloid B-Protein Assembly Towards Therapeutics for Alzheimers Disease Dr. Gal Bitan, Assistant Professor in Residence, Department of Neurology, David Geffen School of Medicine, University of California at Los Angeles Effects of Intracellular Soluble Misfolded A - Targets of Opportunity Dr. Harry LeVine, III, Sanders-Brown Center on Aging, University of Kentucky Soluble Amyloid Oligomer Inhibitors for Treatment of Memory-Related Disorders Dr. Susan Catalano, Ph.D. Director of Discovery Biology, Acumen Pharmaceuticals, Inc. For more information please contact: Elizabeth Lamb, Conference Director, Cambridge Healthtech Institute Fax: : 207-493-4573 E-mail: elamb(_)healthtech.com For sponsorship or exhibiting information, please contact: Suzanne Carroll, Manager, Business Development Phone: 617-630-1352, E-mail: scarroll(_)healthtech.comNOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to (_) to fight spam. Before you send e-mail, you need to change (_) to @
For example: change joe(_)big123comp.com to email@example.com
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.
Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!
|Modified: Sat Oct 22 21:02:48 2005 GMT|
|Page accessed 5276 times since Sat Oct 22 21:02:48 2005 GMT|
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.